Keywords
BRAFV600E MUTATION
magnetic resonance imaging
targeted therapy
How to Cite
Abstract
This article presents a clinical case detailing the diagnostic investigation of a 35-year-old woman with BRAF V600E-associated amelanotic melanoma metastases to the brain and leptomeninges, where a primary tumor site was not identified. MRI findings in this tumor type lack specific signal characteristics and definitive contrast-enhancement patterns.
References
Chacón M., Pfluger Y., Angel M., et al. Uncommon subtypes of malignant melanomas: A review based on clinical and molecular perspectives. Cancers. 2020; 12(9): 2362.-DOI: https://doi.org/10.3390/cancers12092362.
Altamirano De La Cruz A.G., Santoyo Reza C.A., Lugo Rincón-Gallardo F.J., et al. Unseen aggressor: A case of amelanotic melanoma with orbital metastasis and imaging-pathology correlation. Cureus. 2025; 17(7): e88333-DOI: https://doi.org/10.7759/cureus.88333.
Misiąg P., Molik K., Kisielewska M., et al. Amelanotic melanoma - biochemical and molecular induction pathways. Int J Mol Sci. 2024; 25(21): 11502.-DOI: https://doi.org/10.3390/ijms252111502.
Stojkovic-Filipovic J., Kittler H. Dermatoscopy of amelanotic and hypomelanotic melanoma. J Dtsch Dermatol Ges. 2014; 12(6): 467-72.-DOI: https://doi.org/10.1111/ddg.12368.
Меланома кожи и слизистых оболочек. Клинические рекомендации. Рубрикатор клинических рекомендаций: Минздрав России. 2025.-URL: https://cr.minzdrav.gov.ru/view-cr/921_1. [Skin and mucosal melanoma. Clinical recomendations. Clinical recomendations rubricator: Russian Ministry of Health. 2025.-URL: https://cr.minzdrav.gov.ru/view-cr/921_1. (In Rus)].
Guo W., Yin G., Liu H., et al. Matched analysis of the prognosis of amelanotic and pigmented melanoma in head and neck. Acta Otolaryngol. 2020; 140(9): 777-780.-DOI: https://doi.org/10.1080/00016489.2020.1763456.
Alqathama A. BRAF in malignant melanoma progression and metastasis: potentials and challenges. Am J Cancer Res. 2020; 10(4): 1103-1114.-DOI: https://pubmed.ncbi.nlm.nih.gov/32368388/.
Насхлеташвили Д.Р., Банов С.М., Бекяшев А.Х., et al. Метастатическое поражение центральной нервной системы. Клинические рекомендации RUSSCO. Часть 1.1. Злокачественные опухоли. 2025; 15(3s2-1.1): 255-266.-DOI: https://doi.org/10.18027/2224-5057-2025-15-3s2-1.1-11. [Naschletashvili D.R., Banov S.M., Bekyashev A.Kh., et al. Metastatic lesions of the central nervous system. RUSSCO Clinical Guidelines, Part 1.1. Zlokachestvennye Opukholi = Malignant Tumors. 2025; 15(3s2-1.1): 255-66.-DOI: https://doi.org/10.18027/2224-5057-2025-15-3s2-1.1-11. (In Rus)].
Nielsen F.L., Sepehri M. Amelanotic melanomas are often diagnosed at an advanced stage. Ugeskrift Laeger. 2023; 185(17): V10220605.-URL: https://pubmed.ncbi.nlm.nih.gov/37114579/.
Fujita J., Tomita Y., Ichimura K., et al. A unique case of intracranial amelanotic melanoma with BRAF V600E mutation successfully treated via molecular-targeted therapy. NMC Case Rep J. 2023; 10: 67-73.-DOI: https://doi.org/10.2176/jns-nmc.2022-0227.
Zhang S., Wang W., Su X., et al. Amelanotic meningeal melanoma with leptomeningeal dissemination: A case report and systematic literature review. World Neurosurg. 2019; 122: 229-239.-DOI: https://doi.org/10.1016/j.wneu.2018.10.199.
Вторичное злокачественное новообразование головного мозга и мозговых оболочек. Клинические рекомендации Минздрава РФ. 2024.-URL: https://cr.minzdrav.gov.ru/preview-cr/534_3. [Secondary malignant neoplasm of the brain and meninges. Clinical recommendations of the Ministry of Health of the Russian Federation. 2024.-URL: https://cr.minzdrav.gov.ru/preview-cr/534_3 (In Rus)].
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2026 Дария Дмитриевна Дорохова, Мария Геннадьевна Шатохина, Надежда Александровна Плахотина, Геннадий Евгеньевич Труфанов, Daria Dmitrievna Dorokhova, Maria Gennadievna Shatokhina, Nadezhda Aleksandrovna Plakhotina, Gennadiy Evgenievich Trufanov